Global Genome Editing Market – Industry Trends and Forecast to 2027

  • Healthcare
  • Upcoming Report
  • Jul 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Genome Editing Market By Technology (CRISPR, TALEN, ZFN, ANTISENSE, Other Technologies),  Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, Other Applications), Product & Service (Reagents & Consumables, Software & Systems, Services), End User (Pharmaceutical & Biopharmaceutical Industry, Biotechnology Industry, Academic Institutions, CROs, Government Research Organizations, Others), Method (Ex-Vivo, In-Vivo), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027

Genome Editing Market

Market Analysis and Insights of Genome Editing

Genome editing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 13.89 billion by 2027 growing at a CAGR of 15.40% in the above-mentioned forecast period. Increasing awareness among the people regarding the benefits of genome editing which will further create lucrative opportunities for the growth of the market.

Surging level of investment by the government on genomics projects, growing application areas of genomics, introduction of CRISPR-Cas9, increasing competition among the market players, rising demand of synthetic genes and genetically modified organisms which will likely to enhance the growth of the genome editing market in the forecast period of 2020-2027. On the other hand, technological advancement along with rising adoption of agricultural biotechnology which will further bring various opportunities for the growth of the genome editing market in the above mentioned forecast period.

High cost of equipment along with ethical, regulatory and scientific challenges, off-target effects of technology are acting as market restraints for the growth of the genome editing in the above mentioned forecast period.

This genome editing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on genome editing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Genome Editing Market Scope and Market Size

Genome editing market is segmented on the basis of technology, application, product & service, method and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on technology, genome editing market is segmented into CRISPR, TALEN, ZFN, ANTISENSE, and other technologies.
  • On the basis of application, genome editing market is segmented into cell line engineering, genetic engineering, diagnostic applications, drug discovery & development, and other applications. Genetic engineering has been further segmented into animal genetic engineering, and plant genetic engineering.  
  • Based on product & service, genome editing market is segmented into reagents & consumables, software & systems, and services. Services have been further segmented into contract, and in-house.
  • On the basis of method, genome editing market is segmented into ex-vivo, and in-vivo.
  • Genome editing market has also been segmented based on the end user into pharmaceutical & biopharmaceutical industry, biotechnology industry, academic institutions, CROs, government research organizations, and others.

Genome Editing Market Country Level Analysis

Genome editing market is analysed and market size insights and trends are provided by country, technology, application, product & service, method and end user as referenced above.

The countries covered in the genome editing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the genome editing market due to the growing adoption of advanced techniques in research institutes along with increasing occurrences of monogenic diseases, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to the growing number of drug discovery and development activities along with growth of biotechnology and life sciences industry.

The country section of the genome editing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Genome editing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for genome editing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the genome editing market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Genome Editing Market Share Analysis

Genome editing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to genome editing market.

The major players covered in the genome editing market report are Thermo Fisher Scientific Inc., Merck KGaA, Horizon Discovery Ltd., GenScript, Sangamo Therapeutics, Lonza, Editas Medicine, CRISPR Therapeutics., Eurofins Scientific, Precision Biosciences., OXGENE, Intellia Therapeutics, Inc., Synthego, Vigene Biosciences., Epigenie, Integrated DNA Technologies, Inc., New England Biolabs, OriGene Technologies, Inc., TRANSPOSAGEN BIO, Creative Biogene, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions